Literature DB >> 22390489

FcγRIIB: a modulator of cell activation and humoral tolerance.

Birgit Lehmann1, Inessa Schwab, Sybille Böhm, Anja Lux, Markus Biburger, Falk Nimmerjahn.   

Abstract

An immune response needs to be tightly regulated to prevent excessive inflammation, which may result in the destruction of healthy tissues. At the molecular level, the strength of an immune response is determined by the integration of a multitude of positive and negative signals. This review will focus on IgG-dependent immune responses and discuss how the inhibitory receptor FcγRIIB may be involved in regulating both the afferent and efferent phases of such a response. Furthermore, we will discuss recent evidence suggesting that FcγRIIB may have important functions beyond the negative regulation of signals transduced by the B-cell receptor or activating FcγRs and could be responsible for the activity of agonistic antibodies in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390489     DOI: 10.1586/eci.12.5

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  12 in total

Review 1.  IgG Fc Glycosylation in Human Immunity.

Authors:  Taia T Wang
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

Review 2.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

3.  Role of amyloid β protein receptors in mediating synaptic plasticity.

Authors:  Yu Li; Zhongqing Sun; Qiaoyu Cao; Meiwan Chen; Huanmin Luo; Xi Lin; Fei Xiao
Journal:  Biomed Rep       Date:  2017-02-21

Review 4.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

5.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

6.  Comparative gene expression profiling of normal and human colorectal adenomatous tissues.

Authors:  Gongliang DU; Xuehong Fang; Wei Dai; Ruipeng Zhang; Ruiting Liu; Xingbo Dang
Journal:  Oncol Lett       Date:  2014-08-27       Impact factor: 2.967

7.  DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo.

Authors:  Christian H K Lehmann; Anna Baranska; Gordon F Heidkamp; Lukas Heger; Kirsten Neubert; Jennifer J Lühr; Alana Hoffmann; Katharina C Reimer; Christin Brückner; Simone Beck; Michaela Seeling; Melissa Kießling; Didier Soulat; Anne B Krug; Jeffrey V Ravetch; Jeanette H W Leusen; Falk Nimmerjahn; Diana Dudziak
Journal:  J Exp Med       Date:  2017-04-07       Impact factor: 14.307

Review 8.  Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

Authors:  Carlos Rosales
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

Review 9.  Transmembrane domain dependent inhibitory function of FcγRIIB.

Authors:  Junyi Wang; Zongyu Li; Liling Xu; Hengwen Yang; Wanli Liu
Journal:  Protein Cell       Date:  2018-03-01       Impact factor: 14.870

10.  Human adipose-derived mesenchymal stem cells attenuate collagen antibody-induced autoimmune arthritis by inducing expression of FCGIIB receptors.

Authors:  Hyoju Yi; Kwi Young Kang; Youngkyun Kim; Hyerin Jung; Yeri Alice Rim; Narae Park; Juryun Kim; Seung Min Jung; Sung-Hwan Park; Ji Hyeon Ju
Journal:  BMC Musculoskelet Disord       Date:  2015-07-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.